Clinical Safety and Scar Prevention Study of a Topical Antifibrotic Compound FS2.

NCT04186273 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Scar
Cicatrix
Hypertrophic Scar
Skin Graft Scar
Skin Graft Complications
Donor Site Complication
Keloid

Interventions

DRUG: Fibrosis-Inhibiting-Compound-FS2
OTHER: Vehicle moisture balancing base

Sponsor

University of British Columbia